Supply Chain

After facing many unpredictable supply challenges in the past couple years, it’s important to carry any lessons learned into 2022. In a recent Q&A with Cardinal Health and Becker’s Hospital Review, Joe Walsh, founder of Supply Chain Sherpas, discussed how…

The FDA recently posted recall notices for four rapid COVID-19 tests recalled since Jan. 13.

Several hundred providers of Evusheld, a COVID-19 antibody treatment for immunocompromised, were removed from a federal dataset March 16, making it even more difficult to locate the therapy, Kaiser Health News reported March 17.

Medical device recalls, whether voluntary or mandated by the FDA, ensure patient safety. 

Ten health systems have posted job listings for supply chain expertise in the last week: 

A new $350 million medical manufacturing facility producing nitrile gloves is set to be built in Baltimore County, Maryland, according to a March 16 news release from the manufacturer. 

The images and reports from the war in Ukraine have moved several health systems to action, donating their own medical supplies and medicines to be sent to the war-torn nation. 

China's "zero tolerance" approach to COVID-19 outbreaks has led to measures to curb its worst surge since 2020 that will further disrupt global supply chains, The New York Times reported March 15.

In today’s age of unpredictability in the healthcare supply chain industry, taking proactive steps to manage backorders, gain visibility, and implement contingency scenarios is what can set you apart in the industry.

Baxter recalled over 277,000 infusion pumps due to the risk of the device failing to alarm users of repeated upstream occlusion events.